Rapid Micro Biosystems Inc (NAS:RPID)
$ 0.911 -0.025 (-2.67%) Market Cap: 39.20 Mil Enterprise Value: -14.10 Mil PE Ratio: 0 PB Ratio: 0.46 GF Score: 52/100

Rapid Micro Biosystems Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 05:45PM GMT
Release Date Price: $1.38
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Yes. Awesome. Hi, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostic team here at JPMorgan. I've got the Rapid Micro Biosystems team with me up here today. So this will be a standard 40-minute presentation. We'll start off with some slides presented by Rob followed by Q&A.

So for those of you watching online, feel free to submit a question via the Q&A for it all. Otherwise, for those of you in the room, please raise your hand. We do have a mic runner, [that will] hand you a microphone, if you have any.

With that, Rob, let you take your way.

Robert G. Spignesi
Rapid Micro Biosystems, Inc. - CEO, President & Director

Thank you, Rachel. Good morning, everyone. My name is Rob Spignesi. I'm the CEO of Rapid Micro Biosystems. And I'm joined by Sean Wirtjes, our CFO. Thank you for your time. We'll jump right in. By way of background, at Rapid Micro Biosystems, we're focused on a critical part of the global pharmaceutical quality

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot